Article
Absolute quantification of donor-derived cell-free DNA following pediatric and adult heart transplantation
8 May 2025
Abstract excerpt
OBJECTIVE: Traditional rejection surveillance after heart transplantation (HTx) is based on endomyocardial biopsies (EMBs), which are invasive, expensive, and associated with complications. Monitoring using cell-free DNA (cfDNA) is promising, but most studies report only on the donor fraction (DF) as the percentage of donor-derived cfDNA (dd-cfDNA) relative to total cfDNA. We evaluated the performance of dd-cfDNA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
